Pulmonary hypertension related to left heart disease: Insight from a wireless implantable hemodynamic monitor

WHO Group II PH is prevalent and identifies HF patients at risk for adverse outcomes. Ongoing knowledge of hemodynamic variables may allow for more effective treatment strategies to reduce the morbidity of this disease.